This episode of the Atomic Anesthesia Podcast explores the emerging role of Suzetrigine, a novel non-opioid NaV1.8 channel inhibitor, in multimodal surgical pain management. Host Rhea and guest JR Phillips, a DNAP student, discuss the science, efficacy, and safety profile of Suzetrigine, its potential for opioid-sparing strategies, and its unique advantages over traditional opioids and sodium channel blockers. Listen in for an evidence-based look at how this new FDA-approved analgesic could reshape perioperative care, improve patient outcomes, and what its current limitations and future possibilities might be for anesthesia professionals and learners.

To take a quiz about this topic, check out this link: [HERE]

For references for this episode, click [HERE]

💜 LIVE WEBINAR: Save your seat on our monthly, free webinars. Replays are sent to your inbox and you get access to all of our previous webinars.

[WEBINAR SIGN UP]

💜 FREE DOWNLOADS: Grab your copy of customized study plans & worksheets.

[SEE/NCE STUDY PLAN]

[RN ICU DRUG CHART]

💜 CONNECT: 📥 Email questions, comments or topic suggestions to Dr. Temmermand at [email protected], follow us on social media, and sign up for our launch newsletter ⬇️

[NEWSLETTER SIGN-UP]

[INSTAGRAM] [TIKTOK] [YOUTUBE]